Angelia Butcher

A multicenter, randomized, active‐controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia

Jane E. Onken, David B. Bregman, Robert A. Harrington et al. · Transfusion · 2013 · 154 citations

Medicine, Hematology, Pharmacotherapy +16

Clinical efficacy and safety of IV ferric carboxymaltose (FCM) treatment of RLS: A multi-centred, placebo-controlled preliminary clinical trial

Richard P. Allen, Charles H. Adler, Wei Du et al. · Sleep Medicine · 2011 · 145 citations

Medicine, Internal Medicine, Pharmacology +4

Ferric carboxymaltose in patients with iron-deficiency anemia and impaired renal function: the REPAIR-IDA trial

Jane E. Onken, David B. Bregman, Robert A. Harrington et al. · Nephrology Dialysis Transplantation · 2013 · 126 citations

Medicine, Nutrition, Nutritional Sciences +17

Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study

Chaim Charytan, Marializa Bernardo, Todd A. Koch et al. · Nephrology Dialysis Transplantation · 2012 · 76 citations · Full text

Medicine, Nephrology, Pharmacotherapy +17

Direct Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia

Iftikhar Hussaın, Jessica Bhoyroo, Angelia Butcher et al. · Anemia · 2013 · 74 citations · Full text

Medicine, Hematology, Pharmacology +17